Literature DB >> 1383570

Identification of T-cell epitopes on E2 protein of rubella virus, as recognized by human T-cell lines and clones.

D Ou1, P Chong, Y Choi, P McVeigh, W A Jefferies, G Koloitis, A J Tingle, S Gillam.   

Abstract

T-cell epitopes on the E2 protein of rubella virus were studied by using 15 overlapping synthetic peptides covering the E2 protein sequence. The most frequently recognized epitopes on E2 were E2-4 (residues 54 to 74), with 5 of 10 tested T-cell lines responding to it. Two CD4+ cytotoxic T-cell cloned isolated from one T-cell line responded strongly in proliferation assays with peptide E2-4 and were cytotoxic to target cells presenting the E2-4 determinant. Truncated peptides contained within the E2-4 peptide sequence were used to define the T-cell determinants. Results indicated that amino acid residues 54 to 65 were directly involved. Human cell lines with different HLA phenotypes were tested for the capacity to present the antigenic determinants. The results suggested that recognition of peptide E2-4 by T-cell clones was associated with HLA DR7.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1383570      PMCID: PMC240179     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  In vivo induction of cytotoxic T cell response by a free synthetic peptide requires CD4+ T cell help.

Authors:  C Fayolle; E Deriaud; C Leclerc
Journal:  J Immunol       Date:  1991-12-15       Impact factor: 5.422

2.  Recognition of the influenza hemagglutinin by class II MHC-restricted T lymphocytes and antibodies. I. Site definition and implications for antigen presentation and T lymphocyte recognition.

Authors:  L R Brown; N R Nygard; M B Graham; C Bono; V L Braciale; J Gorka; B D Schwartz; T J Braciale
Journal:  J Immunol       Date:  1991-10-15       Impact factor: 5.422

3.  T-cell antigenic sites tend to be amphipathic structures.

Authors:  C DeLisi; J A Berzofsky
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

Review 4.  Structure, function, and genetics of human class II molecules.

Authors:  R C Giles; J D Capra
Journal:  Adv Immunol       Date:  1985       Impact factor: 3.543

5.  The predominance of CD8+ T cells after infection with measles virus suggests a role for CD8+ class I MHC-restricted cytotoxic T lymphocytes (CTL) in recovery from measles. Clonal analyses of human CD8+ class I MHC-restricted CTL.

Authors:  R S van Binnendijk; M C Poelen; K C Kuijpers; A D Osterhaus; F G Uytdehaag
Journal:  J Immunol       Date:  1990-03-15       Impact factor: 5.422

Review 6.  Empirical predictions of protein conformation.

Authors:  P Y Chou; G D Fasman
Journal:  Annu Rev Biochem       Date:  1978       Impact factor: 23.643

7.  Monoclonal antibody-defined epitope map of expressed rubella virus protein domains.

Authors:  J S Wolinsky; M McCarthy; O Allen-Cannady; W T Moore; R Jin; S N Cao; A Lovett; D Simmons
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

8.  Nucleocapsid or spike protein-specific CD4+ T lymphocytes protect against coronavirus-induced encephalomyelitis in the absence of CD8+ T cells.

Authors:  H Körner; A Schliephake; J Winter; F Zimprich; H Lassmann; J Sedgwick; S Siddell; H Wege
Journal:  J Immunol       Date:  1991-10-01       Impact factor: 5.422

9.  Analysis of T- and B-cell epitopes of capsid protein of rubella virus by using synthetic peptides.

Authors:  D Ou; P Chong; B Tripet; S Gillam
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

10.  A CD4+ cytotoxic T-lymphocyte clone to a conserved epitope on human immunodeficiency virus type 1 p24: cytotoxic activity and secretion of interleukin-2 and interleukin-6.

Authors:  R A Littaua; M B Oldstone; A Takeda; F A Ennis
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

View more
  7 in total

1.  Predominant inflammatory cytokine secretion pattern in response to two doses of live rubella vaccine in healthy vaccinees.

Authors:  Neelam Dhiman; Iana H Haralambieva; Robert A Vierkant; V Shane Pankratz; Jenna E Ryan; Robert M Jacobson; Inna G Ovsyannikova; Gregory A Poland
Journal:  Cytokine       Date:  2010-02-01       Impact factor: 3.861

2.  Expression and characterization of virus-like particles containing rubella virus structural proteins.

Authors:  Z Qiu; D Ou; T C Hobman; S Gillam
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

3.  Human T- and B-cell epitopes of E1 glycoprotein of rubella virus.

Authors:  H Chaye; D Ou; P Chong; S Gillam
Journal:  J Clin Immunol       Date:  1993-03       Impact factor: 8.317

4.  Rubella virus-specific cytotoxic T-lymphocyte responses: identification of the capsid as a target of major histocompatibility complex class I-restricted lysis and definition of two epitopes.

Authors:  A E Lovett; C S Hahn; C M Rice; T K Frey; J S Wolinsky
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

5.  Construction of exogenous multiple epitopes of helper T lymphocytes and DNA immunization of its chimeric plasmid with HBV pre-S2/S gene.

Authors:  Wen-Jun Gao; Xiao-Mou Peng; Dong-Ying Xie; Qi-Feng Xie; Zhi-Liang Gao; Ji-Lu Yao
Journal:  World J Gastroenterol       Date:  2004-10-15       Impact factor: 5.742

Review 6.  Molecular biology of rubella virus.

Authors:  T K Frey
Journal:  Adv Virus Res       Date:  1994       Impact factor: 9.937

7.  Analysis of overlapping T- and B-cell antigenic sites on rubella virus E1 envelope protein. Influence of HLA-DR4 polymorphism on T-cell clonal recognition.

Authors:  D Ou; L A Mitchell; M Ho; D Dćarie; A J Tingle; G T Nepom; M Lacroix; M Zrein
Journal:  Hum Immunol       Date:  1994-03       Impact factor: 2.850

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.